Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Muscle-specific kinase (MuSK) is a receptor tyrosine kinase essential for the formation, maintenance, and function of the neuromuscular junction (NMJ). Activated by agrin and LRP4, MuSK triggers AChR clustering and synaptic protein transcription. Autoantibodies against MuSK cause MuSK-MG, characterized by impaired NMJ function.
Blocking MuSK signaling with autoantibodies leads to impaired neuromuscular junction function and downstream consequences in the disease myasthenia gravis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscle-Specific Kinase Receptor (MuSK).